Consequences of hemolytic uremic syndrome among hemodialysis patients

BACKGROUND: Hemolytic uremic syndrome (HUS) is characterized by hemolytic anemia, low platelets, and renal impairment and is mediated by thrombotic microangiopathy (TMA). A common perception is that HUS becomes dormant in dialysis patients with end-stage renal disease (ESRD). We analyzed patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunelli, Steven M., Claxton, Ami, Mehta, Sunil, Anum, Emmanuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439427/
https://www.ncbi.nlm.nih.gov/pubmed/25491936
http://dx.doi.org/10.1007/s40620-014-0149-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439427/
https://www.ncbi.nlm.nih.gov/pubmed/25491936
http://dx.doi.org/10.1007/s40620-014-0149-x

Ejemplares similares